HDAC9 and lung carcinoma: Therefore, the aims of this study were to further investigate HDAC inhibitory activity (in vitro and in silico) and the anti-cancer activity of CU17, as well as exploring its underlying anti-cancer mechanism against human lung cancer A549 cells.